Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

—

Employees—

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

—

Employees—

VERU Key Statistics

Market cap

151.50M

Market cap151.50M

Price-Earnings ratio

-1.53

Price-Earnings ratio-1.53

Dividend yield

—

Dividend yield—

Average volume

5.31M

Average volume5.31M

High today

$1.19

High today$1.19

Low today

$1.00

Low today$1.00

Open price

$1.14

Open price$1.14

Volume

1.76M

Volume1.76M

52 Week high

$1.92

52 Week high$1.92

52 Week low

$0.36

52 Week low$0.36

VERU News

Yahoo Finance 22h

What Makes Veru a New Buy Stock - Yahoo Finance

Veru Inc. (VERU) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upwar...

TipRanks 3d

Veru price target lowered to $5 from $7 at Oppenheimer

Oppenheimer lowered the firm’s price target on Veru to $5 from $7 and keeps an Outperform rating on the shares. The firm notes the company is on the cusp of dos...